Rick Winningham Net Worth & Insider Trades
Rick Winningham - CHIEF EXECUTIVE OFFICER, Theravance Biopharma, Inc
What is Rick Winningham's Net Worth?
The current estimated net worth of Theravance Biopharma, Inc's CHIEF EXECUTIVE OFFICER, Rick Winningham, is estimated to be about $54.03M . Rick Winningham owns about 1,443,364 units of Theravance Biopharma, Inc common stock. In the last 9 years at Theravance Biopharma, Inc, Rick Winningham has sold an estimated value of $5.55M worth.
What is Rick Winningham's Past Insider Trading?
Rick Winningham's largest purchase order was 10,000 units , worth over $245K on August 11, 2017. Rick Winningham's largest sale order was 59,000 units , worth over $559.5K on December 16, 2022. In total, Rick Winningham has made about 25 transactions over 9 years of their time at Theravance Biopharma, Inc. Rick Winningham usually trades in February, with the busiest year in 2022.
Rick Winningham
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What was Rick Winningham's Salary in 2020?
As CHIEF EXECUTIVE OFFICER of Theravance Biopharma, Inc, Rick Winningham has a total base salary of $1,014,455 . Rick Winningham received compensation valued at about $6,577,746 in 2020 after becoming CHIEF EXECUTIVE OFFICER. The vast majority of their compensation came in the form of other earnings, plans or compensations of $579,646 , other earnings, plans or compensations of $579,646 , and other compensation of $6,045 .
What is Rick Winningham's' Mailing Address?
- Mailing address is 901 Gateway Boulevard South San Francisco CA 94080 CA
Theravance Biopharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|---|
Rick E Winningham | 2020 | $1,014,455 | - | $579,646 | - | $579,646 | $6,045 | $6,577,746 |
Rick E Winningham | 2019 | $983,710 | - | $473,906 | - | $473,906 | $5,496 | $5,932,411 |
Rick E Winningham | 2018 | $956,600 | $74,767 | $690,154 | - | $690,154 | $5,000 | $2,522,841 |
Andrew A. Hindman | 2020 | $551,608 | - | $265,278 | - | $265,278 | $5,920 | $2,097,950 |
Andrew A. Hindman | 2019 | $315,000 | $175,000 | $216,000 | $2,204,956 | $216,000 | - | $3,757,956 |
Brett Haumann | 2020 | $572,569 | - | $213,589 | - | $213,589 | $53,267 | $2,742,625 |
Brett Haumann | 2019 | $543,047 | - | $170,000 | - | $170,000 | $42,382 | $2,464,280 |
Brett Haumann | 2018 | $497,810 | $34,125 | $315,000 | - | $315,000 | $414,300 | $1,517,194 |
Vijay Sabesan | 2020 | $407,677 | - | $760,326 | - | $760,326 | $6,541 | $3,077,744 |
Bradford J. Shafer | 2020 | $556,321 | - | $264,999 | - | $264,999 | $6,045 | $2,730,565 |
Bradford J. Shafer | 2019 | $537,403 | - | $215,611 | - | $215,611 | $6,983 | $2,468,848 |
Bradford J. Shafer | 2018 | $518,080 | $33,770 | $311,726 | - | $311,726 | $5,000 | $1,124,537 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1583107/000110465921039784/tm212357-1_def14a.htm
What are Theravance Biopharma, Inc's Past Insider Trades?
Theravance Biopharma, Inc's most recent insider trade came on March 16, 2023 by Richard Graham who sold 2,323 units worth $23.97K . In the last 8 years, insiders at Theravance Biopharma, Inc have sold an estimated value of $150.56M and bought an estimated value of $26.3M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Bradford Shafer, EVP, Rick Winningham, CHIEF EXECUTIVE OFFICER, and Philip Worboys, SVP .
Theravance Biopharma, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |